Ceruloplasmin, superoxide dismutase and copper in autistic patients

Basic and Clinical Pharmacology and Toxicology

Volumn 96, Issue 2, 2005, Pages 146-148

  Tórsdóttir, Gudlaug ^a,b   Hreidarsson, Stefán ^c   Kristinsson, Jakob ^a   Snaedal, Jón ^b   Jóhannesson, Torkell ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c State Diagn and Counselling Centre   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; AUTISM; BLOOD SAMPLING; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REGISTER;

ADULT; AUTISTIC DISORDER; CERULOPLASMIN; COHORT STUDIES; COPPER; FEMALE; HUMANS; MALE; SPECTROPHOTOMETRY, ATOMIC; SUPEROXIDE DISMUTASE;

EID: 14644433652     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto960210.x     Document Type: Article

References (14)

1. Boyett, J. D., H. P. Lehmann & M. F. Beeler: Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation. Acta Clin. Chem. 1976, 69, 233-241.
2. Fatemi, S. H., J. M. Stary & E. A. Egan: Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cell. Mol. Neurobiol. 2002, 22, 139-152.
3. Golse, B., P. Debray-Ritzen, P. Durosay, K. Puget & A. M. Michelson: Alterations in two enzymes: Superoxide dismutase and glutathion peroxidase in developmental infantile psycosis (infantile autism). Revue Neurologique 1978, 134, 699-705.
4. Jackson, M. J. & P. J. Garrod: Plasma zink, copper, and amino acid levels in the blood of autistic children. J. Autism Child Schizophrenia 1978, 8, 203-208.
5. Kemper, T. L. & M. Bauman: Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 1998, 57, 645-652.
6. Lamb, J. A., J. Moore, A. Bailey & A. P. Monaco: Autism: recent molecular genetic advances. Human Mol. Gen. 2000, 9, 861-868.
7. Lauritsen, M. B., O. Mors, P. B. Mortensen & H. Ewald: Medical disorder among inpatients with autism in Denmark according to ICD-8. A nationwide register-based study. J. Autism Developmental Disorders 2002, 32, 115-119.
8. Nebot, C., P. Moutet, P. Huet, J. Z. Xu., J. C. Yadan & J. Chaudiere: Spectrophotometric assay of Superoxide dismutase activity based on the activatedautoxidation of tetracyclic cathechol. Analyt. Biochem. 1993, 214, 442-451.
9. Snaedal, J., J. Kristinsson, S. Gunnarsdóttir, Á. Ólafsdóttir, M. Baldvinsson & T. Jóhannesson: Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 1998, 9, 239-242.
10. Söǧüt, S., S. S. Zoroǧlu, H. Özyurt, H. R. Yilmaz, F. Özuǧurlu, E. Sivaslý, Ö. Yetkin, M. Yanik, H. Tutkun, H. A. Savaş, M. Tarakçioǧlu & Ö. Akyol: Changes in nitric oxide levels and anti-oxidant enzyme activities may have role in the pathophysiological mechanisms involved in autism. Clin. Chim. Acta 2003, 331, 111-117.
11. Tórsdottir, G., J. Kristinsson, S. Sveinbjörnsdóttir, J. Snaedal & T. Jóhannesson: Copper, ceruloplasmin, Superoxide dismutase and ironparameters in Parkinson's disease. Pharmacology & Toxicology 1999, 85, 239-243.
12. Torsdóttir, G., J. Kristinsson, G. Gucrossed d signmundsson, J. Snaedal & J. Jóhannesson: Copper, ceruloplasmin and Superoxide dismutase in patients with amyotrophic lateral sclerosis. Pharmacology & Toxicology 2000, 87, 126-130.
13. Tórsdóttir, G., J. Kristinsson, S. Hreicrossed d signarsson, J. Snaedal & T. Jóhannesson: Copper, ceruloplasmin and Superoxide dismutase in patients with Down's syndrome. Pharmacology & Toxicology 2001, 89, 320-325.
14. Yorbik, O., A. Sayal, C. Akay, D. I. Akbiyik & T. Sohmen: Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins, Leukotriens and Essential Fatty Acids 2002, 67, 341-343.